Clinical Trial Detail

NCT ID NCT02106546
Title Randomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

lung non-small cell carcinoma

Therapies

Veliparib

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.